Your browser of choice has not been tested for use with Barchart.com. If you have issues, please download one of the browsers listed here.
Join Barchart Premier to attend LIVE "Market on Close" program each Friday with John Rowland. FREE 30 Day Trial
Stocks | Futures | Watchlist | News | More
or
Faster, Cleaner, Better.

Hyperliquid Strategies Inc (PURR)

Hyperliquid Strategies Inc (PURR)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Quote Overview for [[ item.sessionDateDisplayLong ]]
[[ rowChartData.labelLow ]]
[[ rowChartData.lowPriceFormatted ]]
[[ rowChartData.lowPrice ]]
[[ rowChartData.labelHigh ]]
[[ rowChartData.highPriceFormatted ]]
[[ rowChartData.highPrice ]]
since [[ rowChartData.lowDate ]]
since [[ rowChartData.highDate ]]
[[ value ]] [[ value ]] ([[ financialData.relativeStrengthDirection14d ]]) ([[ financialData.highPercent1y ]]) ([[ financialData.lowPercent1y ]])
Realtime quote and/or trades are not sourced from all markets.

Fundamentals

See More
  • Market Capitalization, $K 609,923
  • Shares Outstanding, K 123,968
  • Annual Sales, $ 1,000 K
  • Annual Income, $ -16,010 K
  • EBIT $ -301 M
  • EBITDA $ -300 M
  • 60-Month Beta 1.58
  • Price/Sales 613.64
  • Price/Cash Flow N/A
  • Price/Book 1.07

Options Overview Details

View History
  • Implied Volatility 136.11% (-87.19%)
  • Historical Volatility 124.77%
  • IV Percentile 17%
  • IV Rank 0.67%
  • IV High 329.78% on 03/24/26
  • IV Low 134.80% on 03/25/26
  • Expected Move (DTE 16) 0.81 (15.86%)
  • Put/Call Vol Ratio 0.02
  • Today's Volume 780
  • Volume Avg (30-Day) 1,088
  • Put/Call OI Ratio 0.13
  • Today's Open Interest 5,088
  • Open Int (30-Day) 1,960
  • Expected Range 4.28 to 5.90

Analyst Rating / Earnings Estimates

Current Rating
See More
Moderate Buy
Based on 3 analysts offering recommendations.
Earnings Estimates - Current Qtr 03/31/26
See More
  • Average Estimate N/A
  • Number of Estimates 0
  • High Estimate N/A
  • Low Estimate N/A
  • Prior Year $-0.89
  • Growth Rate Est. (year over year) +112,347.19%

Price Performance

See More
Period Period Low Period High Performance
1-Month
4.25 +19.76%
on 03/06/26
6.63 -23.23%
on 03/18/26
+1.01 (+24.75%)
since 02/27/26
3-Month
3.01 +69.10%
on 12/29/25
6.63 -23.23%
on 03/18/26
+1.83 (+56.13%)
since 12/26/25

Most Recent Stories

More News
Hyperliquid Strategies Inc. Announces Milestone with Launch of Options Trading on PURR Common Stock

NEW YORK , March 24, 2026 /PRNewswire/ -- Hyperliquid Strategies Inc (NASDAQ: PURR) ("HSI" or the "Company"), the premier digital asset treasury platform focused on the Hyperliquid ecosystem,...

PURR : 5.09 (+3.46%)
Hyperliquid Strategies Inc Reports Financial Results for the Quarter Ended December 31, 2025

NEW YORK , Feb. 11, 2026 /PRNewswire/ -- Hyperliquid Strategies Inc (NASDAQ: PURR) ("HSI" or the "Company"), the premier digital asset treasury platform focused on the Hyperliquid ecosystem,...

PURR : 5.09 (+3.46%)
Hyperliquid Strategies Inc Announces Webcast to Discuss Results for the Quarter Ended December 31, 2025

NEW YORK , Feb. 5, 2026 /PRNewswire/ -- Hyperliquid Strategies Inc (NASDAQ: PURR) ("HSI" or the "Company"), the premier digital asset treasury platform focused on the Hyperliquid ecosystem,...

PURR : 5.09 (+3.46%)
Hyperliquid Strategies Inc Announces $30 million Stock Repurchase Program

NEW YORK, Dec. 08, 2025 (GLOBE NEWSWIRE) -- Hyperliquid Strategies Inc (NASDAQ: PURR) (“HSI” or the “Company”) announced today that its Board of Directors has authorized a stock repurchase program...

PURR : 5.09 (+3.46%)
Hyperliquid Strategies Inc and Sonnet BioTherapeutics Holdings, Inc. Announce Closing of Business Combination

NEW YORK and PRINCETON, N.J., Dec. 02, 2025 (GLOBE NEWSWIRE) -- Hyperliquid Strategies Inc (“HSI” or the “Company”) and Sonnet BioTherapeutics Holdings, Inc. (NASDAQ: SONN) (“Sonnet”) today...

PURR : 5.09 (+3.46%)
SONN : 1.2600 (-59.35%)

Business Summary

Hyperliquid Strategies Inc is a digital asset treasury company whose primary focus is to maximize shareholder value through accumulating HYPE, the native token of Hyperliquid, a high-performance blockchain custom-built to house all of finance. Hyperliquid Strategies Inc, formerly known as Sonnet BioTherapeutics...

See More

Key Turning Points

3rd Resistance Point 5.65
2nd Resistance Point 5.42
1st Resistance Point 5.26
Last Price 5.09
1st Support Level 4.87
2nd Support Level 4.64
3rd Support Level 4.48

See More

52-Week High 6.63
Fibonacci 61.8% 5.25
Last Price 5.09
Fibonacci 50% 4.82
Fibonacci 38.2% 4.39
52-Week Low 3.01

See More

Want to use this as
your default charts setting?
Save this setup as a Chart Templates
Switch the Market flag
for targeted data from your country of choice.
Open the menu and switch the
Market flag for targeted data from your country of choice.
Want Streaming Chart Updates?
Switch your Site Preferences
to use Interactive Charts
Need More Chart Options?
Right-click on the chart to open the Interactive Chart menu.
Use your up/down arrows to move through the symbols.